ID

31031

Descrizione

ARI103094-Follow-Up Study for REDUCE Study Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT00883909

collegamento

https://clinicaltrials.gov/show/NCT00883909

Keywords

versioni (1)
  1. 12/07/18 12/07/18 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

12 luglio 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Neoplasms, Prostate NCT00883909

Inglese

Eligibility Neoplasms, Prostate NCT00883909

1 moduli  
Criteria
Descrizione

Criteria

any subject who has participated in the reduce study and meets one of the following eligibility criteria is eligible for part a, 2 year observational follow-up study:
Descrizione

Study Subject Participation Status | Criteria Fulfill

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C0243161
UMLS CUI [2,2]
C1550543
completed 4 years on investigational product through the reduce 4 year study visit (visit 10) or
Descrizione

Investigational New Drugs

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013230
was diagnosed with prostate cancer during the reduce study, discontinued investigational product (ip) but participated in reduce prostate cancer follow-up visits through the 4 year study visit (visit 10p) or
Descrizione

Prostate carcinoma | Investigational New Drugs Discontinued | Participation Follow-up

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0600139
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C1444662
UMLS CUI [3,1]
C0679823
UMLS CUI [3,2]
C3274571
withdrew from reduce study visit participation and ip (for any reasons) but participated in reduce follow-up phone calls every 6 months through the 4 year phone call
Descrizione

Participation Clinical Trial Visit Withdrawn | Investigational New Drugs Withdrawn | Participation Follow-up Telephone call

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0679823
UMLS CUI [1,2]
C0008976
UMLS CUI [1,3]
C1512346
UMLS CUI [1,4]
C0424092
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C0424092
UMLS CUI [3,1]
C0679823
UMLS CUI [3,2]
C3274571
UMLS CUI [3,3]
C0302186
exclusion criteria: part a subjects meeting the following criterion must not be enrolled in part a of the study
Descrizione

Exclusion Criteria Part Roman letter

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C0449719
UMLS CUI [1,3]
C0439102
inability/unwillingness to participate in the follow-up study phone calls.
Descrizione

Participation Follow-up Telephone call Unable | Participation Follow-up Telephone call Unwilling

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0679823
UMLS CUI [1,2]
C3274571
UMLS CUI [1,3]
C0302186
UMLS CUI [1,4]
C1299582
UMLS CUI [2,1]
C0679823
UMLS CUI [2,2]
C3274571
UMLS CUI [2,3]
C0302186
UMLS CUI [2,4]
C0558080
inclusion criteria: part b
Descrizione

Inclusion criteria Part Roman letter

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0449719
UMLS CUI [1,3]
C0439102
subjects eligible for enrolment in part b of the study must meet the following criteria:
Descrizione

Criteria Fulfill

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1550543
any subject who was diagnosed with prostate cancer based on a prostate biopsy during participation in the reduce study, regardless of when their reduce study participation ended.
Descrizione

Prostate carcinoma Biopsy of prostate

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0194804
exclusion criteria: part b
Descrizione

Exclusion Criteria Part Roman letter

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C0449719
UMLS CUI [1,3]
C0439102
the exclusion criterion only applies to part a, the 2 year observational follow-up study. there are no exclusion criteria for part b, prostate biopsy tissue study.
Descrizione

Unspecified

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0205370
Ritorna all'inizio della pagina

Similar models

Eligibility Neoplasms, Prostate NCT00883909

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Study Subject Participation Status | Criteria Fulfill
Item
any subject who has participated in the reduce study and meets one of the following eligibility criteria is eligible for part a, 2 year observational follow-up study:
boolean
C2348568 (UMLS CUI [1])
C0243161 (UMLS CUI [2,1])
C1550543 (UMLS CUI [2,2])
Investigational New Drugs
Item
completed 4 years on investigational product through the reduce 4 year study visit (visit 10) or
boolean
C0013230 (UMLS CUI [1])
Prostate carcinoma | Investigational New Drugs Discontinued | Participation Follow-up
Item
was diagnosed with prostate cancer during the reduce study, discontinued investigational product (ip) but participated in reduce prostate cancer follow-up visits through the 4 year study visit (visit 10p) or
boolean
C0600139 (UMLS CUI [1])
C0013230 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C0679823 (UMLS CUI [3,1])
C3274571 (UMLS CUI [3,2])
Participation Clinical Trial Visit Withdrawn | Investigational New Drugs Withdrawn | Participation Follow-up Telephone call
Item
withdrew from reduce study visit participation and ip (for any reasons) but participated in reduce follow-up phone calls every 6 months through the 4 year phone call
boolean
C0679823 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
C1512346 (UMLS CUI [1,3])
C0424092 (UMLS CUI [1,4])
C0013230 (UMLS CUI [2,1])
C0424092 (UMLS CUI [2,2])
C0679823 (UMLS CUI [3,1])
C3274571 (UMLS CUI [3,2])
C0302186 (UMLS CUI [3,3])
Exclusion Criteria Part Roman letter
Item
exclusion criteria: part a subjects meeting the following criterion must not be enrolled in part a of the study
boolean
C0680251 (UMLS CUI [1,1])
C0449719 (UMLS CUI [1,2])
C0439102 (UMLS CUI [1,3])
Participation Follow-up Telephone call Unable | Participation Follow-up Telephone call Unwilling
Item
inability/unwillingness to participate in the follow-up study phone calls.
boolean
C0679823 (UMLS CUI [1,1])
C3274571 (UMLS CUI [1,2])
C0302186 (UMLS CUI [1,3])
C1299582 (UMLS CUI [1,4])
C0679823 (UMLS CUI [2,1])
C3274571 (UMLS CUI [2,2])
C0302186 (UMLS CUI [2,3])
C0558080 (UMLS CUI [2,4])
Inclusion criteria Part Roman letter
Item
inclusion criteria: part b
boolean
C1512693 (UMLS CUI [1,1])
C0449719 (UMLS CUI [1,2])
C0439102 (UMLS CUI [1,3])
Criteria Fulfill
Item
subjects eligible for enrolment in part b of the study must meet the following criteria:
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Prostate carcinoma Biopsy of prostate
Item
any subject who was diagnosed with prostate cancer based on a prostate biopsy during participation in the reduce study, regardless of when their reduce study participation ended.
boolean
C0600139 (UMLS CUI [1,1])
C0194804 (UMLS CUI [1,2])
Exclusion Criteria Part Roman letter
Item
exclusion criteria: part b
boolean
C0680251 (UMLS CUI [1,1])
C0449719 (UMLS CUI [1,2])
C0439102 (UMLS CUI [1,3])
Unspecified
Item
the exclusion criterion only applies to part a, the 2 year observational follow-up study. there are no exclusion criteria for part b, prostate biopsy tissue study.
boolean
C0205370 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial